Story
- SC’s Glivec ruling setback to foreign pharma firms: April 2 2013
- Voices on the Verdict: Times of India, Mumbai, 2 April 2013
- Novartis ruling opens doors for Indian pharma firms… : 2 Apr 2013 | Hindustan Times (Mumbai)
- Novartis verdict a boon for health care in India: April 02, 2013 | Hindustan Times Mumbai
- Key cancer drug will stay cheap after patent ruling: 2 Apr 2013 | Hindustan Times (Mumbai)
- Big pharma’s uncertain future in India | Sushmi Dey | New Delhi April 16, 2013
- The Judgment In Novartis v. India: What The Supreme Court Of India Said | Intellectual Property Watch | Inside Views | 4 April 2013
- India: pariah or pathbreaker of pharma world? | Apr 8, 2013 | DNA
- Injecting purpose into pharma R&D | The Hindu | Business Line | 4 April 2013
- Novartis Loses Historic India Patent Case On Cancer Drug Glivec: Asian Scientist | 5 April 2013
- Brian Druker, who invented the drug’s molecule, says it would benefit patients in the short term | Business Standard | April 3, 2013
- Novartis: India rejects patent plea for cancer drug Glivec | 1 April 2013, BBC Business News
- Cheap drugs triumph as India justices reject patent: International Herald Tribune Asia | 2 Apr 2013
- Ex- J&J India head led fight against patent: Economic Times | 2 April 2013
- Cancer drug down to 8K from 1.2L ? Mumbai Mirror | 2nd April 2013
- Supreme Court rules for cheap cancer drug: TNN | Apr 1, 2013
- SC rejects Novartis’ patent plea for cancer drug Glivec: The Hindu | 1 April 2013
- Novartis loses landmark India patent case on Glivec: Reuters Mumbai / New Delhi | 2 April 2013
- Novartis order may force pharma MNCs to change: ET Bureau | 2 April 2013
- Costly disease for poor country: TNN | 2 Apr 2013
- Supreme Court’s decision on Section 3(d) historic: Anand Grover: Times of India, Mumbai | 2nd April 2013
- PATENT WAR: Drug price negotiation may be way forward: TNN | 2nd April 2013
- Good news for Indian pharma, consumers: Learning with the times: Times of India | 2nd April 2013
- The Judgement will change the cancer scene in India: Mid-Day | 2nd April 2013
- Landmark judgment: No SC cure for Novartis patent pain: DNA | April 2, 2013